Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis C
hepatitis C
Bristol-Myers hepatitis C treatment cures up to 90 pct -study
Yahoo/Zacks.com
Thu, 04/10/14 - 07:35 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
asunaprevir
Gilead Sciences: Pricing Concerns Just Noise?
Barron's
Wed, 04/9/14 - 11:17 am
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
WHO joins clamour to make new hepatitis C pills affordable
Yahoo/Reuters
Wed, 04/9/14 - 08:54 am
WHO
hepatitis C
Sovaldi
Gilead Sciences
Express Scripts assembling anti-Sovaldi coalition to shut out Gilead hep C drug
Fierce Pharma
Tue, 04/8/14 - 11:51 am
Sovaldi
hepatitis C
Gilead Sciences
Express Scripts
drug pricing
[video]A $1 Trillion Drug Market?
Motley Fool
Tue, 04/8/14 - 10:44 am
Gilead Sciences
Solvadi
hepatitis C
hepatitis B
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Mon, 04/7/14 - 12:54 pm
physicians
Sovaldi
Gilead Sciences
hepatitis C
Bristol-Myers submits NDAs for Hep C drugs
Seeking Alpha
Mon, 04/7/14 - 09:57 am
Bristol-Myers Squibb
daclatasvir
asunaprevir
hepatitis C
FDA
Gilead says Japanese hepatitis C trial meets goal
Yahoo/Reuters
Wed, 04/2/14 - 10:01 pm
Gilead Sciences
Japan
hepatitis C
sofosbuvir
Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wed, 04/2/14 - 09:41 pm
Sovaldi
hepatitis C
Gilead Sciences
Will The Hep-C Drug, Sovaldi, Drive Gilead To The Top Of The Biopharm Industry?
Forbes
Tue, 03/25/14 - 08:05 am
hepatitis C
Gilead Sciences
Sovaldi
Sovaldi's Patent War
Seeking Alpha
Mon, 03/24/14 - 06:00 pm
Sovaldi
Gilead Sciences
hepatitis C
patents
Gilead offers Egypt new hepatitis C drug at 99 pct discount
Yahoo/Reuters
Sat, 03/22/14 - 11:48 am
Gilead Sciences
hepatitis C
Sovaldi
Biotech Stocks Weak on Fear That Gilead Drug Pricing Woes Will Spread
TheStreet.com
Fri, 03/21/14 - 11:56 am
drug pricing
Gilead Sciences
Sovaldi
biotech
hepatitis C
U.S. lawmakers ask Gilead about Sovaldi pricing
Yahoo/Reuters
Fri, 03/21/14 - 11:54 am
drug pricing
Sovaldi
hepatitis C
Gilead Sciences
J&J-Medivir Hepatitis C Drug Recommended by EU Regulator
Bloomberg
Fri, 03/21/14 - 10:21 am
JNJ
hepatitis C
Europe
Medivir
Olysio
Read This Twitter Chat About Gilead and the Cost of its Hep C Drug
TheStreet.com
Fri, 03/21/14 - 09:02 am
social media
twitter
hepatitis C
Sovaldi
Gilead Sciences
drug pricing
Big Pharma Ramps Up Hep C Strategies
Yahoo/Investors Business Daily
Wed, 03/19/14 - 07:22 pm
hepatitis C
Sovaldi
Gilead Sciences
daclatasvir
Bristol-Myers Squibb
AbbVie
Enanta Pharmaceuticals
Sovaldi's Terrific Launch
Seeking Alpha
Mon, 03/17/14 - 10:35 am
drug launches
Sovaldi
hepatitis C
Gilead Sciences
Gilead's hot-selling Sovaldi draws more patent attacks
Fierce Pharma
Fri, 03/14/14 - 11:15 am
Sovaldi
Idenix
Merck
Roche
hepatitis C
patents
Gilead Sciences
[video]This Small Biotech Will Profit From the Hep C Drug Race
Motley Fool
Fri, 03/14/14 - 08:41 am
biotech
Enanta Pharmaceuticals
hepatitis C
Gilead Sciences
AbbVie
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »